Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report.

Romero, A

Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report. [electronic resource] - Multiple sclerosis and related disorders May 2020 - 101973 p. digital

Publication Type: Case Reports; Journal Article

2211-0356

10.1016/j.msard.2020.101973 doi


Adult
Alemtuzumab--adverse effects
Humans
Immunologic Factors--adverse effects
Lymphohistiocytosis, Hemophagocytic--chemically induced
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy